Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:27 pm Sale | 2025-12-31 | 13G | ELEDON PHARMACEUTICALS INC ELDN | RA Capital Management, L.P. | 0 0.000% | -3,566,338 (Position Closed) | Filing History |
| 2026-02-17 4:25 pm Sale | 2025-12-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA Capital Management, L.P. | 2,611,733 6.000% | -1,255,000 (-32.46%) | Filing History |
| 2026-02-17 4:23 pm Purchase | 2025-12-31 | 13G | CONTINEUM THERAPEUTICS INC CL CTNM | RA Capital Management, L.P. | 2,179,711 7.200% | 57,711 (+2.72%) | Filing History |
| 2026-02-17 4:21 pm Purchase | 2025-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | RA Capital Management, L.P. | 1,939,065 9.900% | 552,898 (+39.89%) | Filing History |
| 2026-02-17 4:19 pm Sale | 2025-12-31 | 13G | ARCELLX INC ACLX | RA Capital Management, L.P. | 1,267,156 2.200% | -1,520,171 (-54.54%) | Filing History |
| 2026-02-17 4:17 pm Purchase | 2025-12-31 | 13G | ADICET BIO INC ACET | RA Capital Management, L.P. | 960,237 9.900% | 440,954 (+84.92%) | Filing History |
| 2026-02-17 4:15 pm Purchase | 2025-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | RA Capital Management, L.P. | 5,713,852 9.900% | 1,148,985 (+25.17%) | Filing History |
| 2026-02-09 5:01 pm Purchase | 2026-02-02 | 13G | ALX ONCOLOGY HLDGS INC ALXO | RA Capital Management, L.P. | 13,117,106 9.900% | 13,117,106 (New Position) | Filing History |
| 2026-02-02 4:30 pm Purchase | 2026-01-26 | 13G | HELIX ACQUISITION CORP. III US HLXC | RA Capital Management, L.P. | 1,250,000 7.000% | 1,250,000 (New Position) | Filing History |
| 2026-01-16 4:34 pm Purchase | 2026-01-09 | 13G | CENTURY THERAPEUTICS INC IPSC | RA Capital Management, L.P. | 17,944,649 9.900% | 17,944,649 (New Position) | Filing History |
| 2026-01-09 4:45 pm Sale | 2026-01-07 | 13D | CIDARA THERAPEUTICS INC NE CDTX | RA Capital Management, L.P. | 0 0.000% | -3,372,923 (Position Closed) | Filing History |
| 2026-01-07 4:53 pm Purchase | 2025-12-30 | 13G | DISC MEDICINE INC IRON | RA Capital Management, L.P. | 2,228,924 5.900% | 2,228,924 (New Position) | Filing History |
| 2025-12-18 6:31 pm Purchase | 2025-12-18 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 5,411,521 14.000% | 3,066,244 (+130.74%) | Filing History |
| 2025-12-18 6:07 pm Purchase | 2025-12-11 | 13G | OVID THERAPEUTICS INC OVID | RA Capital Management, L.P. | 13,259,735 9.900% | 13,259,735 (New Position) | Filing History |
| 2025-12-18 5:22 pm Purchase | 2025-12-11 | 13G | REZOLUTE INC RZLT | RA Capital Management, L.P. | 15,302,186 9.900% | 15,302,186 (New Position) | Filing History |
| 2025-12-15 7:56 pm Sale | 2025-12-11 | 13D | CLIMB BIO, INC. CLYM | RA Capital Management, L.P. | 18,003,257 33.000% | -13,456,010 (-42.77%) | Filing History |
| 2025-12-15 5:04 pm Unchanged | 2025-12-11 | 13D | WAVE LIFE SCIENCES LTD WVE | RA Capital Management, L.P. | 25,453,010 13.400% | 0 (Unchanged) | Filing History |
| 2025-12-12 5:14 pm Unchanged | 2025-12-05 | 13D | PERCEPTIVE CAP SOLUTIONS CORP PCSC | RA Capital Management, L.P. | 750,000 8.400% | 0 (Unchanged) | Filing History |
| 2025-12-10 4:44 pm Sale | 2025-12-08 | 13G | FULCRUM THERAPEUTICS INC FULC | RA Capital Management, L.P. | 6,053,960 11.200% | -4,175,139 (-40.82%) | Filing History |
| 2025-12-03 4:22 pm Purchase | 2025-11-07 | 13G | BENITEC BIOPHARMA INC BNTC | RA Capital Management, L.P. | 1,850,000 5.500% | 1,850,000 (New Position) | Filing History |